Equities

Haba Laboratories Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
4925:TYO

Haba Laboratories Inc

Actions
Consumer DiscretionaryPersonal Goods
  • Price (JPY)1,746.00
  • Today's Change-6.00 / -0.34%
  • Shares traded3.70k
  • 1 Year change+3.93%
  • Beta0.2890
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

HABA LABORATORIES, INC. is principally engaged in the manufacture and sale of cosmetics and dietary supplements. The Company's main business consists of the research, development, manufacture and distribution of women's and men's cosmetics. The Company offers its products by wholesale distribution to department stores and through mail order services to general customers. It also handles wholesale distribution to retailers and wholesalers, as well as the sale of products at its own retail stores.

  • Revenue in JPY (TTM)12.17bn
  • Net income in JPY674.23m
  • Incorporated1976
  • Employees568.00
  • Location
    Haba Laboratories Inc1-24-11, Kanda Suda-choCHIYODA-KU 101-0041JapanJPN
  • Phone+81 352966250
  • Fax+81 352966267
  • Websitehttps://haba-lab.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ivy Cosmetics Corp2.90bn381.97m2.45bn107.006.951.655.900.846655.6855.68474.61396.940.94231.107.1827,095,050.0012.66-0.792615.78-1.2271.6168.5313.43-1.062.41105.070.0811--7.97-5.23-90.01-3.946.12--
Nippon Shikizai Inc15.83bn234.94m2.57bn486.0010.770.62952.210.1621113.42113.427,587.861,941.390.92914.276.6332,562,700.001.38-0.13712.37-0.199512.3510.921.48-0.17660.48690.67760.6832--17.167.63-45.67-5.27-18.50-4.36
LIPPS Co Ltd-100.00bn-100.00bn4.13bn48.00--1.11----------1,436.66------------------------8.16--0.00--17.25--53.95------
Path Corp2.40bn-515.28m4.32bn61.00--1.65--1.81-7.18-7.1833.5432.630.91981.5013.5139,275,060.00-19.78-25.90-25.19-38.2151.9649.75-21.51-18.301.20-89.310.0981---2.86-1.93-57.36--26.33--
C'BON COSMETICS Co Ltd9.22bn238.77m5.60bn716.0023.480.986113.660.60855.7655.762,152.931,327.441.052.539.6812,873,050.002.73-1.933.98-2.5776.3375.952.59-2.011.49--0.00--4.00-4.46617.20--23.400.00
Premier Antiaging Co Ltd15.57bn465.00m6.22bn216.0013.380.88688.120.399353.3053.301,785.56803.981.452.2910.6572,097,220.004.344.346.226.5975.9877.743.001.912.32--0.15050.00-20.62-4.65131.76-16.256.56--
Adjuvant Holdings Co Ltd3.97bn136.03m6.48bn124.0047.311.5028.131.6317.0117.01495.51535.490.74241.646.7232,009,850.002.543.282.893.7466.1964.663.433.964.35--0.0087.35-7.66-2.60140.78---23.75-12.94
Haba Laboratories Inc12.17bn674.23m6.87bn568.009.790.7268.380.5645178.30178.303,218.482,404.990.99591.2710.8621,427,200.005.52-3.076.93-3.8266.3468.605.54-3.622.6254.190.1384---2.13-8.07127.21-15.18-25.280.00
Soiken Holdings Inc4.87bn163.33m6.88bn81.0042.121.1538.151.416.246.24186.21228.640.72872.6811.9060,135,700.002.432.582.723.0849.1546.683.342.697.29--0.0055.03-6.01-12.2468.18--31.510.00
IZAWA TOWEL Co Ltd-100.00bn-100.00bn7.22bn76.00--1.78----------405.78------------------------2.21--0.4394---1.14---47.55------
Sagami Rubber Industries Co Ltd5.79bn43.96m7.36bn790.00166.210.673116.401.274.054.05533.42999.820.30881.842.557,330,346.000.01613.190.02645.3125.5534.230.05229.540.614337.110.337519.37-6.95-2.82858.44-15.33-30.710.00
Liberta Co Ltd10.03bn46.33m8.90bn128.00242.575.5631.110.88691.211.21331.2952.881.412.834.99--0.65041.791.693.5440.6140.140.46181.230.72471.660.7212--16.1714.44318.81-21.4881.19--
Axxzia Inc14.03bn361.08m9.28bn248.0024.441.1616.980.661515.7515.75609.82332.511.411.8611.8356,572,740.003.609.654.4111.2073.6575.912.558.663.1442.570.084124.1710.5525.73-59.63-14.8718.69--
Data as of Feb 13 2026. Currency figures normalised to Haba Laboratories Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

0.17%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 31 Dec 20253.20k0.08%
Niche Asset Management Ltd.as of 30 Jun 20252.20k0.06%
Dimensional Fund Advisors Ltd.as of 30 Nov 2025900.000.02%
DFA Australia Ltd.as of 30 Nov 2025300.000.01%
Daiwa Asset Management Co. Ltd.as of 24 Apr 20240.000.00%
More ▼
Data from 30 Jun 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.